In the particular case of glaucoma, it has been shown, both in rat glaucoma models and in three patients with advanced glaucoma, that repeated topical administration of exogenous NGF prevented RGC apoptosis or, at least, resulted in a long-term improvement in their eyesight. Here, NGF is linked to glaucoma.